Evidence map›Paper›PMID 27341673›Full record

ArticlePLoS genetics2016

Mapping the Hsp90 Genetic Network Reveals Ergosterol Biosynthesis and Phosphatidylinositol-4-Kinase Signaling as Core Circuitry Governing Cellular Stress.

Teresa R O'Meara, Amanda O Veri, Elizabeth J Polvi, Xinliu Li, Seyedeh Fereshteh Valaei, Stephanie Diezmann, Leah E Cowen

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Imaging-Based Screening Identifies Modulators of theAntimicrobial agents and chemotherapy · 2023
    Article
  9. Imaging-based screening identifies modulators of thebioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Sensing the threat posed by Aspergillus infection.Current opinion in microbiology · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Teresa R O'MearaDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Amanda O VeriDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1764-8439
Elizabeth J PolviDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-7827-826X
Xinliu LiDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Seyedeh Fereshteh ValaeiSchool of Dentistry, University of Detroit Mercy, Detroit, Michigan, United States of America.
Stephanie DiezmannDepartment of Biology and Biochemistry, Milner Centre for Evolution, University of Bath, Claverton Down, Bath, United Kingdom.
Leah E CowenDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CAMichigan United · USUniversity of Bath · GB

Funding

Global analysis of Hsp90 client proteins in Candida albicansF32AI115947 · NIAID · UNIVERSITY OF TORONTO · PI OMEARA, TERESA R. · 2015 to 2017
$168k
NIAID NIH HHS F32 AI115947
6 · The paper itself

Abstract

Candida albicans is a leading human fungal pathogen that causes life-threatening systemic infections. A key regulator of C. albicans stress response, drug resistance, morphogenesis, and virulence is the molecular chaperone Hsp90. Targeting Hsp90 provides a powerful strategy to treat fungal infections, however, the therapeutic utility of current inhibitors is compromised by toxicity due to inhibition of host Hsp90. To identify components of the Hsp90-dependent circuitry governing virulence and drug resistance that are sufficiently divergent for selective targeting in the pathogen, we pioneered chemical genomic profiling of the Hsp90 genetic network in C. albicans. Here, we screen mutant collections covering ~10% of the genome for hypersensitivity to Hsp90 inhibition in multiple environmental conditions. We identify 158 HSP90 chemical genetic interactors, most of which are important for growth only in specific environments. We discovered that the sterol C-22 desaturase gene ERG5 and the phosphatidylinositol-4-kinase (PI4K) gene STT4 are HSP90 genetic interactors under multiple conditions, suggesting a function upstream of Hsp90. By systematic analysis of the ergosterol biosynthetic cascade, we demonstrate that defects in ergosterol biosynthesis induce cellular stress that overwhelms Hsp90's functional capacity. By analysis of the phosphatidylinositol pathway, we demonstrate that there is a genetic interaction between the PI4K Stt4 and Hsp90. We also establish that Stt4 is required for normal actin polarization through regulation of Wal1, and suggest a model in which defects in actin remodeling induces stress that creates a cellular demand for Hsp90 that exceeds its functional capacity. Consistent with this model, actin inhibitors are synergistic with Hsp90 inhibitors. We highlight new connections between Hsp90 and virulence traits, demonstrating that Erg5 and Stt4 enable activation of macrophage pyroptosis. This work uncovers novel circuitry regulating Hsp90 functional capacity and new effectors governing drug resistance, morphogenesis and virulence, revealing new targets for antifungal drug development.

Indexed as

1-Phosphatidylinositol 4-KinaseCandida albicansDrug Resistance, FungalErgosterolFungal ProteinsGene Regulatory NetworksHSP90 Heat-Shock ProteinsMacrophagesMorphogenesisPhosphatidylinositolsPyroptosisSignal TransductionStress, PhysiologicalVirulence1-Phosphatidylinositol 4-KinaseErgosterolFungal ProteinsHSP90 Heat-Shock ProteinsPhosphatidylinositols

Identifiers

PMID27341673
PMCPMC4920384
OpenAlexW2473262875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.